Clean ClAImsFirst Pass

Anterior

Clinician-led AI for health plan clinical reviews

Our take

Anterior, founded in New York in 2023 as Co:Helm by physician Abdel Mahmoud, builds AI that reads clinical documentation and reasons against a health plan's medical policies to support prior authorization and utilization management decisions. Its copilot, Florence, guides nurse reviewers through determinations, auto-approves requests that clearly meet criteria, and leaves an audit trail for every decision. The buyer is the health plan: Anterior pairs the software with embedded clinicians who work alongside plan staff to tune accuracy and drive adoption.

The company reports serving payer organizations covering more than 50 million lives, with production deployments at plans including Geisinger Health Plan and an integration with HealthEdge's GuidingCare platform. KLAS Research independently validated its 99.24% clinical accuracy figure, and customers cite a 76% increase in auto-approvals. After a $20M Series A led by NEA in June 2024, Anterior raised another $40M in February 2026, bringing total funding to $64M. It competes in a crowded payer-AI field but differentiates on clinician-led deployment and speed to production.

What it does

  • AI clinical reasoning against payer medical policies
  • Prior authorization review with nurse-in-the-loop workflow
  • Auto-approval of clean requests, flagging of edge cases
  • Embedded clinicians who tune accuracy in production
  • Audit trails for every determination
  • Five-day average deployment into plan workflows

Where it's strong

  • Clinical accuracy of 99.24% in live production was independently validated by KLAS Research.
  • Founded and staffed by clinicians, which helps with medical director buy-in inside plans.
  • Deploys into existing UM workflows in days rather than the multi-month integrations typical of payer software.

What buyers should weigh

  • Sells only to payers, so provider organizations looking for a submission-side tool are not the buyer.
  • Young company with a small number of named reference customers, so diligence on scale is warranted.
  • State laws increasingly require licensed clinicians to make denial decisions, so buyers must define where AI output stops and human judgment starts.

Latest

In February 2026 Anterior closed a $40M round with NEA, Sequoia, FPV, and Kinnevik, bringing total funding to $64M to expand health plan deployments.

Also in Prior Authorization

Track this market

First Pass covers Prior Authorization and the rest of the getting-paid stack every week.